JBIO Aerovate Therapeutics Inc Gross Profit Rate

Official company branding of Aerovate Therapeutics (JBIO)

Aerovate Therapeutics Inc develops treatments for pulmonary hypertension, relying on global revenue driven by patent protection. The research center is based in Massachusetts, while drug production is outsourced to external biopharmaceutical plants. The company is currently revising its R&D strategy following clinical failures. The gross margin structure demonstrates current operational efficiency, with the metric holding around 0.00.

Return on Gross Profit: Aerovate Therapeutics, Inc. (JBIO) for 04/30/2025 - 11/21/2026

Comprehensive metric breakdowns and analytics for aerovatetx.com (JBIO)

- stock value and consensus price forecast:
Fundamental valuation:JBIO Aerovate Therapeutics
Manufactured product of Aerovate Therapeutics Inc

Gross margin determines the portion of revenue remaining after covering direct production costs, serving as a measure of operational efficiency and the business's pricing power. By analyzing the history of gross margins, an investor assesses the ability of Aerovate Therapeutics Inc (JBIO) to monetize innovative lung drug delivery methods against the backdrop of high R&D expenses and clinical trials.

Key competitors

argenx - Gross Profit Rate|Gross Profitability biontech.de|ABIVAX (ABVX) - Return on Sales by Gross Profit|Gross Margin ADMA|Gross Profit Ratio PTGX|Gross Profitability Immunovant Corp IMVT|Gross Margin Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Gross Profitability|Return on Sales by Gross Profit Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Return on Gross Profit|Aurinia Pharmaceuticals Inc. (AUPH) - Gross Margin|Return on Gross Profit BCRX|Gross Profit Margin Vera Therapeutics Inc VERA|Return on Gross Profit DNTH (Dianthus Pharma)|Return on Sales by Gross Profit Pharvaris N.V.|AbCellera Biologics Inc - Return on Gross Profit|Tourmaline Bio (TRML) - Gross Profit Margin|PGEN - Gross Profitability|Gross Profit Rate PHAR (Pharming Group NV)|NKTR: Gross Margin|Upstream Bio Corp - Gross Profit Rate|Gross Profitability Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Return on Sales by Gross Profit|Gross Margin GOSS|Return on Gross Profit KalVista Pharmaceuticals, Inc. KALV|Gross Profitability Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Gross Profit Margin|SVRA - Gross Profitability|Rigel Pharmaceuticals - Gross Profit Ratio|AnaptysBio Corp (ANAB) - Gross Profitability|ATXS - Return on Sales by Gross Profit|Gross Profitability enGene Holdings Inc.|RAPT: Gross Profit Rate|Gross Margin ACRS|Return on Gross Profit kyvernatx.com KYTX|Gross Margin TLSA (Tiziana Life Sciences, Ltd.)|Gross Margin Cabaletta Bio CABA|VTYX: Return on Gross Profit|Theratechnologies Inc. (THTX) - Return on Gross Profit|AVTX: Gross Margin|ELDN - Return on Sales by Gross Profit|AGEN (Agenus, Inc) - Gross Margin|Gross Margin Climb Bio, Inc.|Gross Profitability Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Gross Profit Rate|Gross Margin ADAG (Adagene Inc)|IMA - Return on Gross Profit|STTK - Gross Profitability|EQ (equilliumbio.com) - Gross Return on Sales|CNTB: Gross Margin|Immunic Inc (IMUX) - Gross Margin|ATRA (Atara Biotherapeutics Inc) - Gross Margin|Gross Return on Sales IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Gross Profit Rate|Adicet Bio, Inc. - Gross Return on Sales|Celularity Inc - Return on Gross Profit|Gross Margin INmune Bio Corporation INMB|Barinthus Biotherapeutics - Gross Margin|Kezar Life Sciences, Inc. (KZR) - Return on Gross Profit|SAB Biotherapeutics Inc. (SABS) - Gross Profitability|Return on Gross Profit Akari Therapeutics plc|Gross Profitability enlivex.com|q32bio.com (QTTB) - Return on Sales by Gross Profit|Gross Margin GOVX|Edesa Biotech, Inc. - Gross Return on Sales|iBio Inc - Return on Gross Profit|Gross Margin Carisma Therapeutics CARM|XTLB - Gross Profitability|BOLT (boltbio.com) - Gross Return on Sales|HCWB: Gross Margin|Aptevo (APVO) - Gross Margin|Gross Profitability AIM ImmunoTech|Return on Gross Profit Aditxt (ADTX)|Return on Gross Profit GRI (GRI Bio Corporation)|XORTX - Gross Return on Sales|Gross Margin HIND (Vyome Holdings Inc.)|Gross Profit Rate REVB|Indaptus - Gross Margin|SCNI (Scinai Immunotherapeutics Ltd.) - Gross Return on Sales|CALI: Gross Margin|Affimed NV - Gross Profit Rate|Gross Profitability Allakos Inc.|Gross Margin HOOKIPA Pharma|Gross Profitability IGM Biosciences, Inc. (IGMS)|ITOS - Gross Profit Margin|Gross Margin OCEA (Ocean Bio)|Gross Profit Rate TCBP|THRD - Gross Profitability